Vaccine-enhanced competition permits rational bacterial strain replacement in the gut
Science · 04.04.2025 · 388 (6742) · 74-81
DOI: 10.1126/science.adp5011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 04.04.2025. Verfasst von Verena Lentsch und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Antibiosis, Escherichia coli, Salmonella typhimurium, Salmonella Vaccines. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Swiss National Science Foundation, European Research Council.
Abstract (Originalsprache)
Colonization of the intestinal lumen precedes invasive infection for a wide range of enteropathogenic and opportunistic pathogenic bacteria. We show that combining oral vaccination with engineered or selected niche-competitor strains permits pathogen exclusion and strain replacement in the mouse gut lumen. This approach can be applied either prophylactically to prevent invasion of nontyphoidal Salmonella strains, or therapeutically to displace an established Escherichia coli. Both intact adaptive immunity and metabolic niche competition are necessary for efficient vaccine-enhanced competition. Our findings imply that mucosal antibodies have evolved to work in the context of gut microbial ecology by influencing the outcome of competition. This has broad implications for the elimination of pathogenic and antibiotic-resistant bacterial reservoirs and for rational microbiota engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland.
- Medical Research Council (MRC) Translational Immunology Discovery Unit, MRC Weatherall Institute of Molecular Medicine (WIMM), John Radcliffe Hospital, University of Oxford, Oxford, UK.
- Sorbonne Université, CNRS, Institut de Biologie Paris-Seine (IBPS), Laboratoire Jean Perrin (LJP), Paris, France.
- Unité de Chronobiologie théorique, Faculté des Sciences, Université Libre de Bruxelles (ULB), Brussels, Belgium.
- Biozentrum, University of Basel, Basel, Switzerland.
- Institute for Microbiology, Department of Biology, ETH Zurich, Zurich, Switzerland.
ORCID-Profile: Verena Lentsch, Andrea Rocker, Claudia Moresi, Louise Larsson, Stefan A Fattinger, Nicolas Wenner, Elisa Cappio Barazzone, Wolf-Dietrich Hardt, Claude Loverdo, Médéric Diard, Emma Slack
Förderung
- Swiss National Science Foundation
- European Research Council
Zitieren
APA
Lentsch, V., Woller, A., Rocker, A., Aslani, S., Moresi, C., Ruoho, N., Larsson, L., Fattinger, S. A., Wenner, N., Barazzone, E. C., Hardt, W. D., Loverdo, C., Diard, M., & Slack, E. (2025). Vaccine-enhanced competition permits rational bacterial strain replacement in the gut. Science, 388(6742), 74-81. https://doi.org/10.1126/science.adp5011
Vancouver
Lentsch V, Woller A, Rocker A, Aslani S, Moresi C, Ruoho N, et al. Vaccine-enhanced competition permits rational bacterial strain replacement in the gut. Science. 2025;388(6742):74-81. doi:10.1126/science.adp5011
BibTeX
@article{Lentsch2025,
author = {Lentsch, Verena and Woller, Aurore and Rocker, Andrea and Aslani, Selma and Moresi, Claudia and Ruoho, Niina and Larsson, Louise and Fattinger, Stefan A and Wenner, Nicolas and Barazzone, Elisa Cappio and Hardt, Wolf-Dietrich and Loverdo, Claude and Diard, Médéric and Slack, Emma},
title = {Vaccine-enhanced competition permits rational bacterial strain replacement in the gut},
journal = {Science},
year = {2025},
volume = {388},
number = {6742},
pages = {74--81},
doi = {10.1126/science.adp5011}
}
EUVIMED